Brazil
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
28.37%
|
Dec. 31, 2023 | USD 16.15 | -4.10% |
|
Brazil |
|
2 |
27.08%
|
Dec. 31, 2023 | USD 2.07 | -3.18% |
|
Brazil |
|
3 |
15.85%
|
Dec. 31, 2023 | USD 2.01 | 1.12% |
|
Brazil |
|
4 |
14.10%
|
Dec. 31, 2023 | USD 4.84 | -1.29% |
|
Brazil |
|
5 |
12.84%
|
Dec. 31, 2023 | USD 1.99 | 0.58% |
|
Brazil |
|
6 |
6.40%
|
Dec. 31, 2023 | USD 0.31 | -3.93% |
|
Brazil |
|
7 |
3.51%
|
Dec. 31, 2023 | USD 1.75 | -1.08% |
|
Brazil |
|
8 |
-55.71%
|
Dec. 31, 2023 | USD 1.67 | 1.07% |
|
Brazil |
The Biotechnology company in Brazil with the highest EBIT Margin is Afya Limited (NasdaqGS: AFYA) at 28.37%.
The Biotechnology company in Brazil with the lowest EBIT Margin is Biomm S.A. (São Paulo Stock Exchange: BIOM3.SA) at -55.71%.
The top 10 Biotechnology companies in Brazil by EBIT Margin are Afya Limited, Blau Farmacêutica S.A., Fleury S.A., Rede D'Or São Luiz S.A., Baumer S.A., Diagnósticos da América S.A., Centro de Imagem Diagnósticos S.A. and Biomm S.A..
The bottom 10 Biotechnology companies in Brazil by EBIT Margin are Biomm S.A., Centro de Imagem Diagnósticos S.A., Diagnósticos da América S.A., Baumer S.A., Rede D'Or São Luiz S.A., Fleury S.A., Blau Farmacêutica S.A. and Afya Limited.